Public ownership of privatized medicine

Covid-19: Public Ownership of Privatized Medicine

Dana Brown, Director of the Next System Project frames the motives of privatized medicine in a system, which values profit over people. While nations are racing to develop a vaccine for Covid-19, how can the public gain ownership of big pharma? “We’re really in a situation now where we’ve got socialized risk and privatized benefit” says Brown.

Publication date: 2020-04-04
Parent publication: Laura Flanders Show
Publication URL: https://www.youtube.com/watch?v=tp26hedehSI&feature=youtu.be

More related work
Default Image

The Democracy Collaborative and The Democracy Collaborative Workers' Union agree to fair severance package for laid-off staff

TDC and union members have agreed to a package of protections that goes well beyond the baseline severance provisions for layoffs agreed to in TDC’s union contract.

read more
Default Image

HAN Anchoring Resilience: Aligning supply chains and impact purchasing for community health summit

by David Zuckerman

The Healthcare Anchor Network (HAN) convened the “Anchoring Resilience: Aligning Supply Chains and Impact Purchasing for Community Health” summit to spark collaboration in the healthcare sector around onshoring and localizing production of PPE and other supplies, with an emphasis on equity, sustainability, and supply chain resilience.

read more
Default Image

Reimagining Personal Protective Equipment (PPE) Supply Chains

by Thomas Hanna, Dana Brown

The Democracy Collaborative prepared a report, created for the Healthcare Anchor Network, which details the current status of the supply chain of PPE, the market shifts caused by COVID-19, and the potential solutions to ensure capacity within US health systems for the future.

read more